- ISIN
- US0311621009
- CUSIP
- 031162100
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- IPO Date
- Jun 17, 1983
Highlights
- Market Cap
- $207.87B
- Enterprise Value
- $258.60B
- EPS (TTM)
- $14.36
- PE Ratio
- 26.81
- PEG Ratio
- 1.54
- Total Revenue (TTM)
- $37.24B
- Gross Profit (TTM)
- $26.61B
- EBITDA (TTM)
- $17.27B
- Year Range
- $269.77 - $398.00
- Target Price
- $350.41
- ROA (TTM)
- 8.43%
- ROE (TTM)
- 84.87%
- Avg. Volume (1M)
- 2M
- Avg. Volume Value (1M)
- $876.84M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
AMGN Performance Chart
Amgen Inc. (AMGN) is up 19.4% since the beginning of the year. At $385 per share, AMGN is trading 3.2% below its 52-week high of $398. Investors who bought $1,000 worth of AMGN shares 5 years ago would now be looking at an investment worth $1,866.
Loading charts...
Compare this symbol against anything
Returns By Period
Amgen Inc. (AMGN) has returned 19.38% so far this year and 33.64% over the past 12 months. Over the last ten years, AMGN has returned 11.54% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
Amgen Inc.
- 1D
- -0.64%
- 1M
- 2.94%
- 6M
- 14.30%
- YTD
- 19.38%
- 1Y
- 33.64%
- 3Y*
- 22.08%
- 5Y*
- 13.29%
- 10Y*
- 11.54%
- ALL TIME*
- 22.83%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
AMGN Monthly Returns History
Based on dividend-adjusted daily data since Sep 7, 1984, AMGN's average daily return is +0.11%, while the average monthly return is +2.19%. At this rate, an investment would double in approximately 2.7 years.
Historically, 57% of months were positive and 43% were negative. The best month was Dec 1987 with a return of +45.9%, while the worst month was Feb 1993 at -41.5%. The longest winning streak lasted 10 consecutive months, and the longest losing streak was 5 months.
On a daily basis, AMGN closed higher 49% of trading days. The best single day was Oct 28, 1987 with a return of +25.3%, while the worst single day was Feb 25, 1993 at -20.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.45% | 14.32% | -9.35% | -1.59% | -2.00% | 7.52% | 6.36% | 19.38% | |||||
| 2025 | 9.51% | 8.80% | 1.13% | -6.62% | -0.07% | -3.11% | 5.69% | -1.71% | -1.92% | 5.75% | 16.58% | -5.25% | 29.67% |
| 2024 | 9.11% | -12.18% | 3.83% | -3.65% | 12.44% | 2.16% | 6.41% | 1.11% | -3.48% | -0.64% | -10.94% | -7.86% | -6.77% |
| 2023 | -3.90% | -7.41% | 4.36% | -0.83% | -7.09% | 0.62% | 5.46% | 10.36% | 4.85% | -4.86% | 6.28% | 6.82% | 13.46% |
| 2022 | 0.96% | 0.56% | 6.77% | -3.57% | 10.98% | -5.23% | 1.71% | -2.15% | -6.20% | 19.94% | 6.67% | -8.30% | 20.43% |
| 2021 | 5.01% | -6.15% | 10.62% | -3.69% | -0.01% | 2.44% | -0.91% | -5.91% | -5.71% | -2.67% | -3.10% | 13.12% | 0.87% |
Benchmark Metrics
Amgen Inc. has an annualized alpha of 19.76%, beta of 0.87, and R2 of 0.18 versus S&P 500 Index. Calculated based on daily prices since September 07, 1984.
- This stock captured 114.71% of S&P 500 Index gains but only 52.10% of its losses - a favorable profile for investors.
- R2 of 0.18 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 19.76%
- Beta
- 0.87
- R²
- 0.18
- Upside Capture
- 114.71%
- Downside Capture
- 52.10%
Return for Risk
Risk / Return Rank
AMGN ranks 79 for risk / return — above 79% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Amgen Inc. (AMGN) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMGN | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.15 | ||
| Sortino ratioReturn per unit of downside risk | +0.07 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.25 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.09 | 2.00 | +0.09 |
| Martin ratioReturn relative to average drawdown | 4.86 | 8.49 | -3.63 |
Dividends
Dividend History
Amgen Inc. provided a 2.54% dividend yield over the last twelve months, with an annual payout of $9.80 per share. The company has been increasing its dividends for 14 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $9.80 | $9.52 | $9.00 | $8.52 | $7.76 | $7.04 | $6.40 | $5.80 | $5.28 | $4.60 | $4.00 | $3.16 |
Dividend yield | 2.54% | 2.91% | 3.45% | 2.96% | 2.95% | 3.13% | 2.78% | 2.41% | 2.71% | 2.65% | 2.74% | 1.95% |
Monthly Dividends
The table displays the monthly dividend distributions for Amgen Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $2.52 | $0.00 | $0.00 | $2.52 | $0.00 | $0.00 | $5.04 | |||||
| 2025 | $0.00 | $2.38 | $0.00 | $0.00 | $2.38 | $0.00 | $0.00 | $2.38 | $0.00 | $0.00 | $2.38 | $0.00 | $9.52 |
| 2024 | $0.00 | $2.25 | $0.00 | $0.00 | $2.25 | $0.00 | $0.00 | $2.25 | $0.00 | $0.00 | $2.25 | $0.00 | $9.00 |
| 2023 | $0.00 | $2.13 | $0.00 | $0.00 | $2.13 | $0.00 | $0.00 | $2.13 | $0.00 | $0.00 | $2.13 | $0.00 | $8.52 |
| 2022 | $0.00 | $1.94 | $0.00 | $0.00 | $1.94 | $0.00 | $0.00 | $1.94 | $0.00 | $0.00 | $1.94 | $0.00 | $7.76 |
| 2021 | $0.00 | $1.76 | $0.00 | $0.00 | $1.76 | $0.00 | $0.00 | $1.76 | $0.00 | $0.00 | $1.76 | $0.00 | $7.04 |
Dividend Yield & Payout
Dividend Yield
Amgen Inc. has a dividend yield of 2.54%, which is quite average when compared to the overall market.
Payout Ratio
Amgen Inc. has a payout ratio of 49.29%, which is quite average when compared to the overall market. This suggests that Amgen Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Amgen Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Amgen Inc. was 63.48%, occurring on Oct 26, 1987. Recovery took 405 trading sessions.
The current Amgen Inc. drawdown is 2.02%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-63.48%Oct 1987 | 7mo 12d | 1y 7mo | 2y 2moMar 1987 - Jun 1989 | Black Monday1987 |
-60.17%Jul 2002 | 1y 11mo | 3y 6d | 4y 12moJul 2000 - Jul 2005 | Dot-com crash2000–2002 |
-59.49%Aug 1993 | 8mo 13d | 1y 10mo | 2y 6moDec 1992 - Jun 1995 | — |
-53.61%Mar 2008 | 2y 6mo | 4y 5mo | 6y 11moSep 2005 - Aug 2012 | Financial crisis2007–2009 |
-51.13%Sep 1986 | 3mo 12d | 4mo 23d | 8mo 5dJun 1986 - Feb 1987 | — |
Drawdown Indicators
| AMGN | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.48% | -56.78% | -6.70% |
Max Drawdown (1Y)Largest decline over 1 year | -16.57% | -9.10% | -7.47% |
Max Drawdown (3Y)Largest decline over 3 years | -22.74% | -18.90% | -3.84% |
Max Drawdown (5Y)Largest decline over 5 years | -24.86% | -25.43% | +0.57% |
Max Drawdown (10Y)Largest decline over 10 years | -24.86% | -33.92% | +9.06% |
Current DrawdownCurrent decline from peak | -2.02% | -1.58% | -0.44% |
Average DrawdownAverage peak-to-trough decline | -16.74% | -10.70% | -6.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.11% | 2.14% | +4.97% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Amgen Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Amgen Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for AMGN, comparing it with other companies in the Drug Manufacturers - General industry. Currently, AMGN has a P/E ratio of 26.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for AMGN compared to other companies in the Drug Manufacturers - General industry. AMGN currently has a PEG ratio of 1.5. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AMGN relative to other companies in the Drug Manufacturers - General industry. Currently, AMGN has a P/S ratio of 5.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AMGN in comparison with other companies in the Drug Manufacturers - General industry. Currently, AMGN has a P/B value of 22.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with AMGN
Add Amgen Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with AMGN